Cardiol Therapeutics Inc.
CRDL
$0.94
$0.011.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.23M | -6.04M | -5.77M | -5.84M | -9.33M |
| Total Depreciation and Amortization | 18.60K | 18.40K | 17.40K | 34.60K | 147.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.64M | 2.25M | 878.40K | 1.10M | 5.45M |
| Change in Net Operating Assets | -451.70K | 485.20K | -105.80K | 707.50K | -1.96M |
| Cash from Operations | -5.03M | -3.29M | -4.98M | -4.00M | -5.70M |
| Capital Expenditure | -2.20K | -4.70K | -8.30K | -4.40K | -5.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.20K | -4.70K | -8.30K | -4.40K | -5.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80K | -13.80K | -13.80K | -13.80K | -4.60K |
| Issuance of Common Stock | 0.00 | 34.30K | -- | 21.36M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -2.65M | -- |
| Cash from Financing | -10.10K | 14.80K | -9.60K | 13.35M | -3.40K |
| Foreign Exchange rate Adjustments | 268.10K | -405.50K | -75.10K | 1.15M | -260.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.77M | -3.68M | -5.08M | 10.50M | -5.97M |